Clinical Trials List
2015-11-23 - 2022-04-01
Phase III
Terminated9
ICD-9162.9
Malignant neoplasm of bronchus and lung, unspecified
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/07/01
Investigators and Locations
Co-Principal Investigator
- Sin-Syue Li 無
- Yu-Min Yeh 無
- Shang-Yin Wu 無
- Seu-Chun Yang 無
- Wen-Pin Su 無
- Wu-Chou Su Division of Hematology & Oncology
- Yau-Lin Tseng 無
- Yi-Ting Yen 無
- Wei-Pang Chung 無
The Actual Total Number of Participants Enrolled
0 Terminated
Audit
None
Co-Principal Investigator
- Jih-Hsiang Lee Division of Hematology & Oncology
- JIN-YUAN SHIH Division of Thoracic Medicine
- 陳冠宇 無
- 廖唯昱 無
- CHAO-CHI HO CHAO-CHI HO 無
- Chia-Chi Lin 無
- SHUENN-WEN KUO 無
- 楊景堯 無
- 林宗哲 無
- 許嘉林 無
- James Chih-Hsin Yang Division of Hematology & Oncology
- JANG-MING LEE 無
- 張逸良 無
- JIN-SHING CHEN 無
- 廖斌志 無
The Actual Total Number of Participants Enrolled
0 Terminated
Audit
None
Co-Principal Investigator
- 蔡俊明 Division of Thoracic Medicine
- Chao-Hua Chiu Division of Thoracic Medicine
- Hsu-ching Huang 無
- Yung-Hung Luo Division of Thoracic Medicine
- 蕭慈慧 Division of Thoracic Medicine
- 趙恒勝 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 林正耀 無
- 陳彥勳 無
- 陳昭勳 Division of Hematology & Oncology
- Shang-Wen Chen 無
- Shang-Hung Chen Division of Hematology & Oncology
- 曹朝榮 無
- 蕭聖諺 無
- 林建良 無
- 黃文聰 無
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Shih-Hong Li 無
- Chih-Hsi Kuo 無
- Yi-Chen Wu 無
- Ping-Chih Hsu 無
- Chao Yin-Kai 無
- Chih-Liang Wang 無
- 柯皓文 無
- Cheng-Ta Yang 無
- 枋岳甫 無
- Chih-Hung Chen 無
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
163 participants
-
Global
700 participants